Annandale, NJ, United States of America

Nancy Behrens

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Nancy Behrens

Introduction

Nancy Behrens is a notable inventor based in Annandale, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of new therapeutic agents. Her work focuses on creating innovative solutions for various medical conditions.

Latest Patents

Nancy Behrens holds a patent for "5-Amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents." This patent describes a new class of compounds that are beneficial in treating and managing psoriasis, inflammatory bowel syndrome, cutaneous leishmaniasis, and certain types of cancer. Her invention represents a promising advancement in the field of medicine.

Career Highlights

Behrens is currently employed at Merck & Co., Inc., a leading global healthcare company. Her role at Merck allows her to contribute to the development of innovative therapies that can improve patient outcomes. With her expertise, she plays a vital part in the research and development of new medications.

Collaborations

Throughout her career, Nancy has collaborated with esteemed colleagues, including Barbara A. Azzolina and Donald Hupe. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Nancy Behrens exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly her patented work, highlight her commitment to improving healthcare through scientific advancements. Her ongoing efforts continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…